Paysign to Host Fourth Quarter and Full Year 2023 Earnings Call
HENDERSON, Nev.–(BUSINESS WIRE)–Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings,... Read more.
Civitas Resources, Inc. Announces Share Repurchase From NGP
DENVER–(BUSINESS WIRE)–Civitas Resources, Inc. (NYSE: CIVI) (“Civitas” or the “Company”), today announced the execution of a definitive agreement... Read more.
Ryan Specialty Reports Fourth Quarter 2023 Results; Initiates Quarterly Dividend
– Total Revenue grew 22.5% year-over-year to $532.9 million – – Organic Revenue Growth Rate of 16.0% year-over-year – – Net Income... Read more.
NYSE Group Consolidated Short Interest Report
NEW YORK–(BUSINESS WIRE)–NYSE today reported short interest as of the close of business on the settlement date of February 15, 2024. SETTLEMENT DATE... Read more.
Civitas Announces Fourth Quarter and Full-Year 2023 Results
2024 Outlook Focused on Free Cash Flow and Cash Returns to Shareholders; Production Guidance Maintained with 7% Reduction in Capital DENVER–(BUSINESS WIRE)–Civitas... Read more.
Fuel Tech Schedules 2023 Fourth Quarter and Full Year Financial Results and Conference Call
WARRENVILLE, Ill.–(BUSINESS WIRE)–Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering for the optimization of combustion... Read more.
Alliance Resource Partners, L.P. Names Steven Schnitzer Senior Vice President, General Counsel and Secretary
TULSA, Okla.–(BUSINESS WIRE)–Alliance Resource Partners, L.P. (NASDAQ: ARLP) today announced that Steven Schnitzer will join ARLP as Senior Vice President,... Read more.
Luminar Reports Fourth Quarter & Full Year 2023 Business Update and Financials
All Eyes On Upcoming Launch with Volvo Cars ORLANDO, Fla.–(BUSINESS WIRE)–Today, Luminar (NASDAQ: LAZR), a leading global automotive technology company,... Read more.
XP Inc Announces New Share Repurchase Program
SÃO PAULO–(BUSINESS WIRE)–XP Inc. (Nasdaq: XP), announced today that its board of directors has approved a new share repurchase program, which aims... Read more.
Incyte Announces U.S. Food and Drug Administration Grants Priority Review for Axatilimab for the Treatment of Chronic Graft-Versus-Host Disease
– Priority Review acceptance based on positive results of AGAVE-201 study WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today announced... Read more.